Omnicell VP Sells $100,000 in Stock (OMCL)
Omnicell (NASDAQ:OMCL) VP Marga Ortigas-Wedekind sold 4,000 shares of the stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of $25.00, for a total transaction of $100,000.00. Following the transaction, the vice president now directly owns 80,903 shares of the company’s stock, valued at approximately $2,022,575. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
OMCL has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Omnicell (NASDAQ:OMCL) in a research note to investors on Wednesday, August 21st. They now have a $24.00 price target on the stock. Analysts at Cowen and Company raised their price target on shares of Omnicell (NASDAQ:OMCL) from $18.00 to $21.00 in a research note to investors on Friday, August 2nd. They now have a “market perform” rating on the stock.
Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $22.00.
Omnicell (NASDAQ:OMCL) traded up 0.20% during mid-day trading on Wednesday, hitting $25.03. 264,781 shares of the company’s stock traded hands. Omnicell has a 52 week low of $12.61 and a 52 week high of $25.22. The stock’s 50-day moving average is $23.28 and its 200-day moving average is $20.12. The company has a market cap of $872.0 million and a P/E ratio of 39.65.
Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, August 1st. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.25 by $0.02. The company had revenue of $93.70 million for the quarter, compared to the consensus estimate of $92.42 million. During the same quarter last year, the company posted $0.20 earnings per share. Omnicell’s revenue was up 24.3% compared to the same quarter last year. On average, analysts predict that Omnicell will post $1.05 earnings per share for the current fiscal year.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.